Royal Bank of Canada’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-143
| Closed | – | – | 6460 |
|
|
2024
Q2 | $0 | Sell |
143
-857
| -86% | – | ﹤0.01% | 6692 |
|
|
2024
Q1 | $2K | Sell |
1,000
-11,460
| -92% | -$22.9K | ﹤0.01% | 6205 |
|
|
2023
Q4 | $33K | Buy |
12,460
+2,137
| +21% | +$5.66K | ﹤0.01% | 5613 |
|
|
2023
Q3 | $24K | Buy |
10,323
+8,178
| +381% | +$19K | ﹤0.01% | 5617 |
|
|
2023
Q2 | $8K | Buy |
+2,145
| New | +$8K | ﹤0.01% | 6073 |
|
|
2022
Q4 | – | Sell |
-219
| Closed | – | – | 6801 |
|
|
2022
Q3 | $0 | Buy |
219
+199
| +995% | – | ﹤0.01% | 6987 |
|
|
2022
Q2 | $0 | Sell |
20
-2,640
| -99% | – | ﹤0.01% | 6921 |
|
|
2022
Q1 | $13K | Sell |
2,660
-4,039
| -60% | -$19.7K | ﹤0.01% | 6341 |
|
|
2021
Q4 | $76K | Buy |
6,699
+3,848
| +135% | +$43.7K | ﹤0.01% | 5591 |
|
|
2021
Q3 | $42K | Buy |
2,851
+812
| +40% | +$12K | ﹤0.01% | 5736 |
|
|
2021
Q2 | $24K | Sell |
2,039
-190
| -9% | -$2.24K | ﹤0.01% | 5965 |
|
|
2021
Q1 | $27K | Buy |
2,229
+2,026
| +998% | +$24.5K | ﹤0.01% | 5748 |
|
|
2020
Q4 | $3K | Buy |
203
+155
| +323% | +$2.29K | ﹤0.01% | 6227 |
|
|
2020
Q3 | $1K | Buy |
48
+7
| +17% | +$146 | ﹤0.01% | 5912 |
|
|
2020
Q2 | $1K | Sell |
41
-69
| -63% | -$1.68K | ﹤0.01% | 5923 |
|
|
2020
Q1 | $2K | Sell |
110
-1,527
| -93% | -$27.8K | ﹤0.01% | 5774 |
|
|
2019
Q4 | $26K | Buy |
+1,637
| New | +$26K | ﹤0.01% | 5142 |
|
|
2018
Q4 | – | Sell |
-2,808
| Closed | -$26K | – | 5857 |
|
|
2018
Q3 | $26K | Sell |
2,808
-1,497
| -35% | -$13.9K | ﹤0.01% | 4937 |
|
|
2018
Q2 | $52K | Buy |
+4,305
| New | +$52K | ﹤0.01% | 4565 |
|